These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11752041)

  • 1. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.
    Boots JMM; van Duijnhoven EM; Christiaans MHL; Wolffenbuttel BHR; van Hooff JP
    J Am Soc Nephrol; 2002 Jan; 13(1):221-227. PubMed ID: 11752041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
    PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.
    Filler G; Neuschulz I; Vollmer I; Amendt P; Hocher B
    Nephrol Dial Transplant; 2000 Jun; 15(6):867-71. PubMed ID: 10831643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.
    Ravindran VK; Moore RH; Dunseath G; Luzio SD; Owens DR; Baboolal K
    Transplantation; 2009 Jun; 87(12):1870-6. PubMed ID: 19543067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.
    Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Vos PF; Blom HJ; Sweep FC; Demacker PN; Hilbrands LB
    J Am Soc Nephrol; 2003 Jul; 14(7):1880-8. PubMed ID: 12819249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study.
    Duijnhoven EMV; Boots JMM; Christiaans MHL; Wolffenbuttel BHR; Hooff JPV
    J Am Soc Nephrol; 2001 Mar; 12(3):583-588. PubMed ID: 11181807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
    van Duijnhoven EM; Christiaans MHL; Boots JMM; Nieman FHM; Wolffenbuttel BHR; van Hooff JP
    J Am Soc Nephrol; 2002 Jan; 13(1):213-220. PubMed ID: 11752040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.
    Gelens MACJ; van Hooff JP; Usvyat L; Christiaans MH
    J Diabetes Complications; 2017 Sep; 31(9):1384-1388. PubMed ID: 28720321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study.
    Nordheim E; Birkeland KI; Åsberg A; Hartmann A; Horneland R; Jenssen T
    Eur J Endocrinol; 2018 Oct; 179(4):251-259. PubMed ID: 30299895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of blood concentration of tacrolimus with serum cystatin C in renal transplant recipients and effect of tacrolimus on glucose and lipid metabolism].
    Zhong ZB; Mo LQ; Chen Y; Zheng P; Yang XX
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jun; 37(6):817-820. PubMed ID: 28669959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in tacrolimus trough levels after steroid withdrawal.
    van Duijnhoven EM; Boots JM; Christiaans MH; Stolk LM; Undre NA; van Hooff JP
    Transpl Int; 2003 Oct; 16(10):721-5. PubMed ID: 12827231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
    Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.
    David-Neto E; Lemos FC; Fadel LM; Agena F; Sato MY; Coccuza C; Pereira LM; de Castro MC; Lando VS; Nahas WC; Ianhez LE
    Transplantation; 2007 Jul; 84(1):50-5. PubMed ID: 17627237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression.
    Sharif A; Ravindran V; Moore RH; Dunseath G; Luzio S; Owens DR; Baboolal K
    Transplantation; 2010 Feb; 89(3):327-33. PubMed ID: 20145524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus.
    Midtvedt K; Jenssen T; Hartmann A; Vethe NT; Bergan S; Havnes K; Åsberg A
    Nephrol Dial Transplant; 2011 Nov; 26(11):3767-72. PubMed ID: 21471328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period.
    Havrdova T; Jedinakova T; Lipar K; Skibova J; Saudek F
    Transplant Proc; 2011 Nov; 43(9):3270-2. PubMed ID: 22099774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
    Ruangkanchanasetr P; Sanohdontree N; Supaporn T; Sathavarodom N; Satirapoj B
    Ann Transplant; 2016 Dec; 21():765-774. PubMed ID: 27980321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe.
    Loucaidou M; Borrows R; Cairns T; Griffith M; Hakim N; Palmer A; Papalois V; Taube D; McLean AG
    Transplant Proc; 2005 May; 37(4):1795-6. PubMed ID: 15919469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
    Gelens MA; Christiaans MH; van Hooff JP
    Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.